Profile: The Binding Site manufactures immunodiagnostic assays in the fields of autoimmune disease and multiple myeloma. We offer autoimmune diagnostics, infectious diseases and radial immunodiffusion. We specialize in the research, development and manufacture immunodiagnostic assays in the fields of multiple myeloma and investigation of the immune response. Our serum kappa & lambda free immunoglobulin light chains for improved detection and monitoring of B cell dyscrasia.

The company was founded in 1988, has ~60 employees and is ISO 9001, ISO 9002, CE certified.

FDA Registration Number: 2083566

51 to 62 of 62 Products/Services (Click for related suppliers)  Page: 1 [2]

• Indirect Immunofluorescent Anti-Thyroid Antibody

• Indirect Immunofluorescent Antimitochondrial Antibody Test (FDA Code: DBM / 866.5090) An antimitochondrial antibody immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the antimitochondrial antibodies in human serum. The measurements aid in the diagnosis of diseases that produce a spectrum of autoantibodies (antibodies produced against the body's own tissue), such as primary biliary cirrhosis (degeneration of liver tissue) and chronic active hepatitis (inflammation of the liver).

• Infectious Diseases Assays

• Lipoproteins Radial Immunodiffusion Test (FDA Code: JHP / 862.1475) A lipoprotein test system is a device intended to measure lipoprotein in serum and plasma. Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases.

• Peroxidase IgA Antisera (FDA Code: CZL / 866.5510) An immunoglobulins A, G, M, D, and E immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the immunoglobulins A, G, M, D, an E (serum antibodies) in serum. Measurement of these immunoglobulins aids in the diagnosis of abnormal protein metabolism and the body's lack of ability to resist infectious agents.

• Peroxidase-conjugated Anti-IgE (FDA Code: DGO / 866.5510)

• Plasma Coagulation Control (FDA Code: GGN / 864.5425) A multipurpose system for in vitro coagulation studies is a device consisting of one automated or semiautomated instrument and its associated reagents and controls. The system is used to perform a series of coagulation studies and coagulation factor assays.

• Qualitative and Quantitative Factor Deficiency Test (FDA Code: GGP / 864.7290) A factor deficiency test is a device used to diagnose specific coagulation defects, to monitor certain types of therapy, to detect coagulation inhibitors, and to detect a carrier state (a person carrying both a recessive gene for a coagulation factor deficiency such as hemophilia and the corresponding normal gene).

• Radial Immunodiffusion Plates and Equipment (FDA Code: JZQ / 866.4800) A radial immunodiffusion plate for clinical use is a device that consists of a plastic plate to which agar gel containing antiserum is added. In radial immunodiffusion, antigens migrate through gel which originally contains specific antibodies. As the reagents come in contact with each other, they combine to form a precipitate that is trapped in the gel matrix and immobilized.

• Radial Immunodiffusion Reader

• Rhodamine Alpha-2-Macroglobulin (FDA Code: DDT / 866.5620) Analpha -2-macroglobulin immunological test system is a device that consists of the reagents used to measure by immunochemical techniques thealpha -2-macroglobulin (a serum protein) in plasma. Measurement ofalpha -2-macroglobulin may aid in the diagnosis of blood-clotting or clot lysis disorders.

• Secondary Antibody Test (FDA Code: KTS / 866.5510)